EXECUTION BROKER - LISTED DERIVATIVES - NEW YORK

Kepler CheuvreuxNew York, NY
$150,000 - $225,000

About The Position

This is a rare opportunity to build and shape the U.S. listed derivatives execution platform for an established global financial institution expanding its footprint in New York. The role sits at the heart of institutional order flow, with real ownership of execution across time zones — bridging European liquidity with U.S. markets and directly influencing how orders are handled, routed, and executed. You will be part of a fully integrated transatlantic derivatives team, working in continuous coordination with colleagues in New York and Europe. This is a collaborative platform — not a silo — with constant communication, shared coverage, and unified execution standards across regions. If you want a seat where execution still means judgment, responsibility, and impact — not just button-pushing — this is it.

Requirements

  • 5+ years in listed derivatives execution
  • Strong expertise in equity options and futures markets
  • Proven institutional order handling experience
  • Deep understanding of market microstructure and execution strategies
  • Strong familiarity with execution platforms (TT, CME, Fidessa, Itiviti, etc.)
  • Series 7, 63, and 3 licenses required
  • Calm under pressure in fast-moving markets
  • Highly collaborative and globally minded
  • Execution-driven mindset with strong ownership mentality

Responsibilities

  • Handling complex listed options and futures orders for institutional clients
  • Ensuring best execution, liquidity access, and efficient order routing
  • Applying deep market microstructure expertise to execution strategy
  • Managing the handover of European order flow into U.S. markets
  • Acting as a key coordination point between global desks
  • Helping build and refine the U.S. execution framework
  • Shaping execution workflows, processes, and client coverage model
  • Working closely with institutional clients and internal stakeholders
  • Supporting the expansion of the firm’s derivatives execution presence in the U.S.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service